持续的基因组倍增促进了卵巢癌的进化性和免疫失调
bioRxiv : the preprint server for biology
|July 29, 2024
概括
全基因组倍增 (WGD) 积极推动瘤进化和卵巢癌转移. 这种持续的过程促进了遗传多样性和免疫抑制,影响了治疗耐药性.
科学领域:
- 基因组学就是基因组学.
- 癌症生物学 癌症生物学
- 进化生物学 进化生物学
背景情况:
- 全基因组翻倍 (WGD) 是固体瘤发展,耐药性和转移的一个关键因素.
- 了解WGD的进化动态对于癌症治疗策略至关重要.
研究的目的:
- 研究WGD作为瘤进化中的持续突变过程.
- 模拟 WGD 在瘤细胞种群中的分布及其与基因组多样化和免疫反应的联系.
- 确定WGD在卵巢癌中的进化时间和表型后果.
主要方法:
- 从65个高度血清卵巢癌 (HGSOC) 样本中对29481个瘤细胞进行单细胞全基因组测序.
- 开发和应用基于突变的WGD计时的"doubleTime"方法.
- 集成的单细胞RNA测序和免疫光显微镜.
主要成果:
- WGD是一种活跃的突变过程,促进细胞多样性,染色体不稳定性和HGSOC中的微核化.
- 确定了WGD驱动瘤进化的三种不同的模式:具有多样化的单元起源,不同背景的独立事件和晚期的克隆扩张.
- 二倍体瘤显示炎症信号和cGAS-STING激活,而WGD瘤显示静止和免疫抑制的表型.
结论:
- WGD是一种进化活跃的过程,增强了瘤的进化能力.
- WGD动态影响基因组多样化,并导致不同的表型状态,包括免疫抑制.
- 研究结果提供了关于WGD在晚期卵巢癌进展和免疫逃避中的作用的见解.
更多相关视频
09:08Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
6.7K
09:40Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
2.6K
相关概念视频
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Cancers Originate from Somatic Mutations in a Single Cell
11.8K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.8K
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
Oogenesis
63.6K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.6K
DNA Damage Can Stall the Cell Cycle
2.6K
2.6K
Nondisjunction
3.8K
Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate correctly and move to the opposite poles of the cells. This produces daughter cells with abnormal chromosome numbers. Nondisjunction is common during anaphase I or anaphase II of meiosis. Mutations in synaptonemal complex proteins that attach homologous chromosomes increase the chances of nondisjunction in anaphase I of meiosis I. In contrast, mutations in topoisomerases and condensins that hold...
3.8K
